PROGNOSTIC FACTORS IN 281 CHILDREN WITH NONMETASTATIC RHABDOMYOSARCOMA (RMS) AT DIAGNOSIS

被引：49
|
作者：
RODARY, C
REY, A
OLIVE, D
FLAMANT, F
QUINTANA, E
BRUNATMENTIGNY, M
OTTEN, J
VOUTE, PA
机构：
[1] INST CURIE, F-75231 PARIS 05, FRANCE
[2] ST PIERRE HOSP, BRUSSELS, BELGIUM
[3] CHILDRENS HOSP, NANCY, FRANCE
[4] LEON BERARD CTR, LYON, FRANCE
[5] EMMA KINDERZIEKENHUIS HOSP, AMSTERDAM, NETHERLANDS
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1988年 / 16卷 / 02期
关键词：
D O I：
10.1002/mpo.2950160202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：71 / 77
页数：7
相关论文
共 50 条
  • [31] Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma
    Lo, Wen-Ling
    Huang, Wei-Hao
    Yeh, Chien-Fu
    IN VIVO, 2022, 36 (06): : 2965 - 2972
  • [32] RHABDOMYOSARCOMA (RMS) OF THE HEAD AND NECK (H AND N), INCLUDING ORBITS (ORB) IN CHILDREN - RESULTS OF THE INTERGROUP RHABDOMYOSARCOMA STUDY (IRS)
    SUTOW, WW
    LINDBERG, RD
    GEHAN, EA
    RAGAB, AH
    RANEY, RB
    RUYMANN, FB
    SOULE, EH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 343 - 343
  • [33] PROGNOSTIC FACTORS IN CHILDREN WITH RHABDOMYOSARCOMA - A STUDY ON 253 CHILDREN REGISTERED BY THE INTERNATIONAL-SOCIETY-OF-PEDIATRIC-ONCOLOGY (SIOP)
    RODARY, C
    REY, A
    REZVANI, A
    FLAMANT, F
    BULLETIN DU CANCER, 1988, 75 (02) : 213 - 223
  • [34] Prognostic significance of residual mass at the end of therapy in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS). IV experience.
    Hawkins, DS
    Stoner, J
    Kao, S
    Rodeberg, D
    Hayes-Jordan, A
    Qualman, S
    Wolden, S
    Meyer, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 800S - 800S
  • [35] What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma (RMS) arising in the abdominal wall?
    Beech, TR
    Moss, RL
    Anderson, JA
    Maurer, HA
    Qualman, SA
    Brenneman, JA
    Crist, WA
    Wiener, ES
    PEDIATRICS, 1998, 102 (03) : 788 - 788
  • [36] The Prognostic Index and Risk Rank are Better Prognostic Markers for Children with Rhabdomyosarcoma
    Huang, J.
    Liu, J.
    Chen, H.
    Cai, R.
    Shi, B.
    Guo, L.
    Zhen, Z.
    Wang, J.
    Sun, F.
    Zhang, Y.
    Sun, X.
    Lu, S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S492 - S493
  • [37] Clinical outcomes and prognostic factors of parameningeal rhabdomyosarcoma in children and adolescents: results of two consecutive protocols
    Duan, Chao
    He, Sidou
    Ma, Xiaoli
    Wang, Shengcai
    Jin, Mei
    Zhao, Wen
    Wang, Xisi
    Liu, Zhikai
    Yu, Tong
    He, Lejian
    Wang, Xiaoman
    Ni, Xin
    Su, Yan
    TRANSLATIONAL PEDIATRICS, 2024, 13 (07)
  • [38] Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram
    De Salvo, Gian Luca
    Del Bianco, Paola
    Minard-Colin, Veronique
    Chisholm, Julia
    Jenney, Meriel
    Guillen, Gabriela
    Devalck, Christine
    Van Rijn, Rick
    Shipley, Janet
    Orbach, Daniel
    Kelsey, Anna
    Rogers, Timothy
    Guerin, Florent
    Scarzello, Giovanni
    Ferrari, Andrea
    Cesen Mazic, Maja
    Merks, Johannes H. M.
    Bisogno, Gianni
    CANCER, 2024, 130 (13) : 2351 - 2360
  • [39] PROGNOSTIC FACTORS IN BLADDER AND BLADDER-PROSTATE RHABDOMYOSARCOMA
    LAQUAGLIA, MP
    GHAVIMI, F
    HERR, H
    MANDELL, L
    PENNENBERG, D
    HAJDU, S
    EXELBY, PR
    JOURNAL OF PEDIATRIC SURGERY, 1990, 25 (10) : 1066 - 1072
  • [40] Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience
    Berlanga, Pablo
    Canete, Adela
    Salom, Marta
    Montalar, Joaquin
    Guasp, Maria
    Marco, Alfredo
    Castel, Victoria
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (03) : 176 - 181
12345